Clinical Trial Update: Study to Assess Efficacy and Safety of Bone Marrow Derived Stem Cells in Patients With Critical Limb Ischemia [Phase 2]

View source ↗

Summary

The study assessed the efficacy and safety of bone marrow–derived stem cells in patients with critical limb ischemia. The Phase 2 trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• Bone marrow-derived stem cells

Snippet

Sponsor: Lifecells, LLC. | Conditions: Critical Limb Ischemia | Phase 2 | Status: COMPLETED